Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors

Withdrawn before enrolling · Phase 1

Conditions studied: Kidney Cancer

In brief

RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with kidney tumors.

Key facts

Study ID

NCT00445757

Run by

Case Comprehensive Cancer Center

People needed

0

Starts

2007-01-01

Expected to finish

2010-03-01

Last updated by the study team

2012-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.